Secondary data from a variety of sources including company websites, newspaper articles, academic
articles, investor analyses, and consultant reports were employed to describe “the how,” i.e., the actual
ways and means of the working relationships between AMCs and their industry partners. While it is
generally accepted that these partnerships have become an increasingly common approach both to
promote public health objectives and to produce healthcare innovations, it is anticipated that their
nature will continue to evolve over time (see Figure 2), and many believe that their full potential have
yet to be realized. The relationship between AMCs and biopharmaceutical companies is naturally
complementary and historically has lent itself to the formation of joint research enterprises. In fact,
about half of all biotechnology firms have been founded by university scientists, many of whom still
have their academic affiliations, and a recent survey of AMCs indicated that over half of their
researchers already conduct drug and device clinical trials.
Secondary data from a variety of sources including company websites, newspaper articles, academicarticles, investor analyses, and consultant reports were employed to describe “the how,” i.e., the actualways and means of the working relationships between AMCs and their industry partners. While it isgenerally accepted that these partnerships have become an increasingly common approach both topromote public health objectives and to produce healthcare innovations, it is anticipated that theirnature will continue to evolve over time (see Figure 2), and many believe that their full potential haveyet to be realized. The relationship between AMCs and biopharmaceutical companies is naturallycomplementary and historically has lent itself to the formation of joint research enterprises. In fact,about half of all biotechnology firms have been founded by university scientists, many of whom stillhave their academic affiliations, and a recent survey of AMCs indicated that over half of theirresearchers already conduct drug and device clinical trials.
การแปล กรุณารอสักครู่..